Relationship of Serum Estrogens and Metabolites with Area and Volume Mammographic Densities

Hormones and Cancer

Volumn 6, Issue 2-3, 2015, Pages 107-119

  Gierach, Gretchen L ^a,h   Patel, Deesha A ^a   Falk, Roni T ^a   Pfeiffer, Ruth M ^a   Geller, Berta M ^b   Vacek, Pamela M ^b   Weaver, Donald L ^b   Chicoine, Rachael E ^b   Shepherd, John A ^c   Mahmoudzadeh, Amir Pasha ^c   Wang, Jeff ^c,d   Fan, Bo ^c   Herschorn, Sally D ^b   Xu, Xia ^e   Veenstra, Timothy ^e,f   Fuhrman, Barbara ^g   Sherman, Mark E ^a   Brinton, Louise A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^f CN Diagnostics   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ABNORMALITIES; ADULT; AGED; BLOOD; BREAST TUMOR; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAMMARY GLAND; MAMMOGRAPHY; MIDDLE AGED; RADIOGRAPHY; TANDEM MASS SPECTROMETRY;

ADULT; AGED; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; ESTROGENS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TANDEM MASS SPECTROMETRY;

EID: 84939948778     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-015-0216-3     Document Type: Article

References (52)

1. McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159–1169. doi:10.1158/1055-9965.epi-06-0034
2. Martin LJ, Boyd NF (2008) Mammographic density—potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10(1):201
3. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30–37
4. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RML (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case–control study. J Natl Cancer Inst 103:744–752. doi:10.1093/jnci/djr079
5. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354(3):270–282
6. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7(12):1133–1144
7. Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E et al (2013) Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 19(18):4972–4982. doi:10.1158/1078-0432.CCR-13-0029
8. Hong CC, Tang BK, Rao V, Agarwal S, Martin L, Tritchler D, Yaffe M, Boyd NF (2004) Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. Breast Cancer Res 6(4):R338–R351
9. Haakensen V, Biong M, Lingjaerde O, Holmen M, Frantzen J, Chen Y, Navjord D et al (2010) Expression levels of uridine 5′-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density. Breast Cancer Res 12(4):R65
10. Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F et al (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14(10):1009–1019. doi:10.1016/s1470-2045(13)70301-2
11. Key T, Appleby P, Barnes I, Reeves G, Endogenous Hormones, and Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606–616
12. Becker S, Kaaks R (2009) Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk? Recent Results Cancer Res 181:135–157
13. Bertrand KA, Eliassen AH, Hankinson SE, Gierach GL, Xu X, Rosner B, Ziegler RG, Tamimi RM (2012) Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat 136(1):277–287. doi:10.1007/s10549-012-2240-0
14. Fuhrman BJ, Brinton LA, Pfeiffer RM, Xu X, Veenstra TD, Teter BE, Byrne C et al (2012) Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study. Cancer Epidemiol Biomarkers Prev 21(9):1582–1591. doi:10.1158/1055-9965.EPI-12-0247
15. Maskarinec G, Heak S, Morimoto Y, Custer L, Franke AA (2012) The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. Cancer Epidemiol 36(5):e310–e316. doi:10.1016/j.canep.2012.03.014
16. Maskarinec G, Williams AE, Rinaldi S, Kaaks R (2005) Mammographic densities and urinary hormones in healthy women with different ethnic backgrounds. In: Li J, Li S, Llombart-Bosch A (eds) Hormonal carcinogenesis IV. New York, Springer, pp 277–286
17. Riza E, dos Santos Silva I, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A (2001) Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomarkers Prev 10(6):627–634
18. Falk RT, Brinton LA, Dorgan JF, Fuhrman BJ, Veenstra TD, Xu X, Gierach GL (2013) Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case–control study. Breast Cancer Res 15(2):R34. doi:10.1186/bcr3416
19. Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV Jr, Cauley JA, Hue TF et al (2014) Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis 35(2):346–355. doi:10.1093/carcin/bgt367
20. Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, Willett WC, Hankinson SE, Ziegler RG (2011) Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 72(3):696–706. doi:10.1158/0008-5472.can-11-2507
21. Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, Sue LY, Buys SS et al (2012) Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 104(4):326–339. doi:10.1093/jnci/djr531
22. Yaffe M (2008) Mammographic density. Measurement of mammographic density. Breast Cancer Res 10(3):209
23. Gierach GL, Geller BM, Shepherd JA, Patel DA, Vacek PM, Weaver DL, Chicoine RE et al (2014) Comparison of mammographic density assessed as volumes and areas among women undergoing diagnostic image-guided breast biopsy. Cancer Epidemiol Biomarkers Prev 23(11):2338–2348. doi:10.1158/1055-9965.EPI-14-0257
24. Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG (2007) Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 79(20):7813–7821
25. Prevrhal S, Shepherd JA, Smith-Bindman R, Cummings SR, Kerlikowske K (2002) Accuracy of mammographic breast density analysis: results of formal operator training. Cancer Epidemiol Biomarkers Prev 11(11):1389–1393
26. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39(10):1629–1638
27. Shepherd JA, Kerlikowske K, Ma L, Duewer F, Fan B, Wang J, Malkov S, Vittinghoff E, Cummings SR (2011) Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 20(7):1473–1482. doi:10.1158/1055-9965.EPI-10-1150
28. Malkov S, Wang J, Kerlikowske K, Cummings SR, Shepherd JA (2009) Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. Med Phys 36(12):5525–5536
29. Box GEP, Cox DR (1964) An analysis of transformations. J R Stat Soc 26:211–522
30. Falk RT, Xia X, Keefer L, Veenstra TD, Ziegler RG (2008) A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 17(12):3411–3418. doi:10.1158/1055-9965.epi-08-0355
31. Fuhrman BJ, Xu X, Falk RT, Dallal CM, Veenstra TD, Keefer LK, Graubard BI, Brinton LA, Ziegler RG, Gierach GL (2014) Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry. Cancer Epidemiol Biomarkers Prev 23(12):2649–2657
32. Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 14(6):1411–1417
33. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882
34. Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT (2007) Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer 121:2506–2511
35. Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen/progestin interventions mammographic density study. Am J Epidemiol 162(9):826–834
36. Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E et al (2008) Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat 108(1):57–67
37. McCormack VA, Dowsett M, Folkerd E, Johnson N, Palles C, Coupland B, Holly JM, Vinnicombe SJ, Perry NM, dos Santos Silva I (2009) Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women. Breast Cancer Res 11(3):R38. doi:10.1186/bcr2325
38. Schoemaker MJ, Folkerd EJ, Jones ME, Rae M, Allen S, Ashworth A, Dowsett M, Swerdlow AJ (2014) Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study. Br J Cancer 110(7):1898–1907. doi:10.1038/bjc.2014.64
39. Sprague BL, Trentham-Dietz A, Gangnon RE, Buist DS, Burnside ES, Bowles EJ, Stanczyk FZ, Sisney GS (2011) Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer 2(1):62–72. doi:10.1007/s12672-010-0056-0
40. Tamimi RM, Hankinson SE, Colditz GA, Byrne C (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 14(11):2641–2647
41. Verheus M, Peeters PH, van Noord PA, van der Schouw YT, Grobbee DE, van Gils CH (2007) No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res 9(4):R53
42. Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E, Healey CS et al (2006) Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15(8):1502–1508. doi:10.1158/1055-9965.epi-05-0828
43. Woolcott CG, Courneya KS, Boyd NF, Yaffe MJ, McTiernan A, Brant R, Jones CA et al (2013) Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat 1–11. doi:10.1007/s10549-013-2534-x
44. Vachon C, van Gils C, Sellers T, Ghosh K, Pruthi S, Brandt K, Shane Pankratz V (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9(6):217
45. Siiteri PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr 45(1):277–282
46. Aitken Z, McCormack VA, Highnam RP, Martin L, Gunasekara A, Melnichouk O, Mawdsley G et al (2010) Screen-film mammographic density and breast cancer risk: a comparison of the volumetric standard mammogram form and the interactive threshold measurement methods. Cancer Epidemiol Biomark Prev 19(2):418–428. doi:10.1158/1055-9965.epi-09-1059
47. Jeffreys M, Warren R, Highnam R, Davey Smith G (2008) Breast cancer risk factors and a novel measure of volumetric breast density: cross-sectional study. Br J Cancer 98(1):210–216. doi:10.1038/sj.bjc.6604122
48. Lokate M, Kallenberg MG, Karssemeijer N, Van den Bosch MA, Peeters PH, Van Gils CH (2010) Volumetric breast density from full-field digital mammograms and its association with breast cancer risk factors: a comparison with a threshold method. Cancer Epidemiol Biomarkers Prev 19(12):3096–3105. doi:10.1158/1055-9965.EPI-10-0703
49. McCormack VA, Highnam R, Perry N, dos Santos Silva I (2007) Comparison of a new and existing method of mammographic density measurement: intramethod reliability and associations with known risk factors. Cancer Epidemiol Biomarkers Prev 16(6):1148–1154. doi:10.1158/1055-9965.EPI-07-0085
50. Fishman J, Schneider J, Hershcope RJ, Bradlow HL (1984) Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem 20(4B):1077–1081
51. Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. JNCI 99(15):1178–1187. doi:10.1093/jnci/djm062
52. Loud JT, Gierach GL, Veenstra TD, Falk RT, Nichols K, Guttmann A, Xu X, Greene MH, Gail MH (2014) Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers. Breast Cancer Res Treat 143(3):517–529. doi:10.1007/s10549-013-2821-6